Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 6Recruiting 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 1

Conditions

Breast Neoplasms 305Carcinoma, Non-Small-Cell Lung 287Colorectal Neoplasms 159Prostatic Neoplasms 158Carcinoma, Hepatocellular 144Neoplasms 137Leukemia, Myeloid, Acute 131Lung Neoplasms 117Squamous Cell Carcinoma of Head and Neck 108Multiple Myeloma 104Triple Negative Breast Neoplasms 102Recurrence 101Pancreatic Neoplasms 96Stomach Neoplasms 94Ovarian Neoplasms 89Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Esophageal Neoplasms 68Uterine Cervical Neoplasms 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Melanoma 67Brain Neoplasms 67Rectal Neoplasms 64Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 58Myelodysplastic Syndromes 55Lymphoma 55Esophageal Squamous Cell Carcinoma 54

Interventions

epigallocatechin gallate 1Tablets 1Pravastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Deglutition Disorders × Clear all
NCT07217938 2026-03-03

TRADstat

Peter MacCallum Cancer Centre, Australia

Phase 2 Recruiting
48 enrolled
Head & Neck

Deglutition Disorders, Head and Neck Neoplasms

NCT06398405 2024-05-03

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
72 enrolled
Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms

NCT04901234 2023-12-12

ART-OPC

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 2 Recruiting
120 enrolled
Head & Neck

Deglutition Disorders, Oropharyngeal Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡